GSK · 10000+ people · Public
Director, Oncology Translational Medicine, Clinical Biomarkers
- Grimsby
- Hybrid
- US$189,750 – US$316,250 pa
- Director
Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.
IHC/IF · Liquid Biopsy · ctDNA +3